#174 Lp(a) and ASCVD Risk: 5 Pearls Segment

If your patient asks you about a left atrial appendage closure device, what should you tell them? In the latest episode of the Beyond Journal Club podcast from CORE IM and NEJM Group, the hosts will help you: Understand the trade-offs: stroke prevention, bleeding, procedural risk ...  Show more

“Should you stop screening for colorectal cancer (CRC) at 75?” This episode explores how to individualize screening decisions based on life expectancy, prior colonoscopy findings, and procedural risks. Learn how to navigate these nuanced conversations, avoid age-based assumptions ...  Show more

CardioNerds Dan Ambinder and Dr. Devesh Rai join cardiology fellows and National Lipid Association lipid scholars Dr. Oby Ibe from Temple University and Dr. Elizabeth Epstein from Scripps Clinic. They discuss a case involving a patient with elevated Lp(a). Dr. Jessica Pena provid ...  Show more

Pronounced, el-pee-little-a, this lipoprotein is simply described as a low density lipoprotein (LDL) that has an apoprotein "a" attached to it...but Lp(a) goes far beyond its description in terms of its structure, function, and the role that it plays in cardiovascular health a ...

In this episode of Geriatric Pharmacy Focus, we welcome back Dr. Thomas Dayspring for an in-depth discussion on lipoprotein(a). We explore what it is, how to test for it, available treatment options, and the pharmacist's role in raising awareness for this genetic cardiovascula ...